Zonisamide 25mg and 100mg out of stock
We have been informed by pharmaceutical company Actavis (which was recently acquired by Teva UK), that due to wholesaler issues, Zonisamide tablets in 25mg and 100mg are out of stock until early May 2019.
Epilepsy Society calls for urgent review of medicines supply chain
Epilepsy Society is calling on Health Secretary Matt Hancock to commission an urgent review of the medicines supply chain as patients are forced to trawl around pharmacies in search of their drugs.
How to manage if there is a shortage of your epilepsy medication
We are receiving many calls to our Helpline alongside online enquiries from people who are experiencing difficulties in getting their epilepsy medication. Here, our medical director Professor Ley Sander looks at the problem and explains what you can do to manage the situation and how the Government is tackling current shortages.
Royal Colleges publish new guidance around use of valproate for women and girls of childbearing age with epilepsy
New guidance brings greater clarity for doctors and patients in implementing MHRA regulations around use of sodium valproate for women and girls of childbearing age with epilepsy
Charity hopes guidance will help to address some of the complex situations that arise in individual cases
Shortage of Epanutin Infatabs 50 mg
We have been advised by the pharmaceutical company Pfizer that due to manufacturing delays there will be a shortage of Epanutin (phenytoin) Infatabs 50mg from 1 May through to July or August 2019.
Teva to discontinue Oxcarbazepine 150mg tablets
Teva UK are discontinuing their version of Oxcarbazepine 150mg tablets in October 2019. There is currently stock available. They have already discontinued their 300mg and 600mg tablets.